A protective role of IL-30 via STAT and ERK signaling pathways in macrophage-mediated inflammation

Biochemical and Biophysical Research Communications

Volumn 435, Issue 2, 2013, Pages 306-312

  Liu, Xiao ^a   Wang, Zhen ^a   Ye, Ning ^a   Chen, Zhongwen ^a   Zhou, Xikun ^a   Teng, Xiu ^a   Huang, Nongyu ^a   Liu, Ning ^a   Zhang, Nannan ^a   Guan, Ting ^a   Mao, Yongqiu ^a   Kan, Bin ^a   Wei, Yuquan ^a   Li, Jiong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

IL 30; Liver injury; LPS; Macrophage; STAT ERK

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GALACTOSAMINE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 1BETA; INTERLEUKIN 30; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROTECTION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DOWN REGULATION; DRUG CYTOTOXICITY; GENE EXPRESSION REGULATION; IMMUNOSTIMULATION; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; HEPATITIS; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; INTERLEUKINS; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; STAT TRANSCRIPTION FACTORS;

HUMAN HERPESVIRUS 4;

EID: 84878462097     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.136     Document Type: Article

References (33)

1. Farazi P.A., DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 2006, 6:674-687.
2. Thomas J.A., Pope C., Wojtacha D., Robson A.J. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 2011, 53:2003-2015.
3. Shimozato O., Sato A., Kawamura K., Chiyo M. The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses. Immunology 2009, 128:e816-e825.
4. Stumhofer J.S., Tait E.D. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 2010, 11:1119-1126.
5. Stumhofer J.S., Laurence A. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
6. Liu J., Guan X., Ma X. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J. Exp. Med. 2007, 204:141-152.
7. Villarino A.V., Huang E., Hunter C.A. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 2004, 173:715-720.
8. Kamimura D., Ishihara K., Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 2003, 149:1-38.
9. Scheller J., Ohnesorge N., Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand. J. Immunol. 2006, 63:321-329.
10. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
11. Szabo G., Romics L., Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 2002, 6:1045-1066.
12. Kim A.R., Cho J.Y., Zou Y. Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells. Arch. Pharm. Res. 2005, 28:297-304.
13. Yoon S.B., Lee Y.J. Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J. Ethnopharmacol. 2009, 125:286-290.
14. Becker S., Mundandhara S. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies. Toxicol. Appl. Pharmacol. 2005, 207:269-275.
15. Wan J.Y., Gong X., Zhang L. Protective effect of baicalin against lipopolysaccharide/d-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. Eur. J. Pharmacol. 2008, 587:302-308.
16. Nakama T., Hirono S., Moriuchi A. Etoposide prevents apoptosis in mouse liver with d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology 2001, 33:1441-1450.
17. Kim S.H., Kim Y.S. Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. J. Pharmacol. Sci. 2008, 106:225-233.
18. Li C.S., Zhang Q., Lee K.J. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J. Gastroenterol. Hepatol. 2009, 24:1692-1696.
19. Dibra D., Cutrera J., Xia X. Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology 2012, 55:1204-1214.
20. Tunon M.J., Alvarez M., Culebras J.M., Gonzalez-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J. Gastroenterol. 2009, 15:3086-3098.
21. Dejager L., Libert C. Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in d-galactosamine-sensitized mice. Cytokine 2008, 42:55-61.
22. Kuhla A., Eipel C. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1069-G1076.
23. Ikeda T., Abe K., Kuroda N. The inhibition of apoptosis by glycyrrhizin in hepatic injury induced by injection of lipopolysaccharide/d-galactosamine in mice. Arch. Histol. Cytol. 2008, 71:163-178.
24. Jesse C.R., Wilhelm E.A. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. J. Appl. Toxicol. 2009, 29:323-329.
25. Han D., Hanawa N., Saberi B. Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis. Free Radic. Biol. Med. 2006, 41:627-639.
26. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
27. Vignali D.A., Kuchroo V.K. IL-12 family cytokines: immunological playmakers. Nat. Immunol. 2012, 13:722-728.
28. Rose-John S. IL-6 Trans-Signaling via the soluble IL-6 receptor: Importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 2012, 8:1237-1247.
29. Yasukawa H., Ohishi M., Mori H., Murakami M. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 2003, 4:551-556.
30. Blonska M., Czuba Z.P., Krol W. Effect of flavone derivatives on interleukin-1beta (IL-1beta) mRNA expression and IL-1beta protein synthesis in stimulated RAW 264.7 macrophages. Scand. J. Immunol. 2003, 57:162-166.
31. Fukuda T., Mogami A., Tanaka H. A multiple cytokine production modulator, protects against d-galactosamine and lipopolysaccharide-induced hepatitis. Life Sci. 2006, 79:822-827.
32. Panaro M.A., Gagliardi N., Saponaro C. Toll-like receptor 4 mediates LPS-induced release of nitric oxide and tumor necrosis factor-alpha by embryonal cardiomyocytes: biological significance and clinical implications in human pathology. Curr. Pharm. Des. 2010, 16:766-774.
33. Gonzalo S., Grasa L., Arruebo M.P. Extracellular signal-regulated kinase (ERK) is involved in LPS-induced disturbances in intestinal motility. Neurogastroenterol. Motil. 2011, 23:e80-e90.